Press release
A University of Dundee-led programme that will train the next generation of barley researchers has received a multi-million pound investment.
Press release
A University of Dundee-led programme that will train the next generation of barley researchers has received a multi-million pound investment.
Press release
A University of Dundee researcher is to join an international collaboration that brings scientists from academia together with one of the world’s largest pharma companies to help develop new drugs for cancer and other devastating diseases.
Press release
A novel vaccine production platform that could prove decisive in the battle against Streptococcus is among the University of Dundee innovations recognised in Scotland’s largest company creation programme for the higher education sector.
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.
Press release
Work to build on Dundee’s world-class expertise in biomedical sciences is set to begin in earnest after the ‘Growing the Tay Cities Biomedical Cluster’ project was officially signed off by the Tay Cities Region Joint Committee today (February 19).
Press release
An entrepreneurial scientist from the University of Dundee has proven his business concept is more than skin deep after winning one of the country’s top enterprise awards
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).
Press release
Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene